FME.XETRA Fresenius Medical Care AG & Co. KGaA

Healthcare Health Care Providers & Services XETRA Stock Exchange
42.32 EUR
Close of Nov 5, 2026
33.24 45.90
Market cap
EUR 11.0B
P/E
14.2x
P/B
0.83x
ROE
5.2%
Dividend yield
3.85%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is FME.XETRA undervalued?

Graham number
Price42.32
Graham value58.47
Discount27.6%

FME.XETRA trades 27.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fresenius Medical Care AG & Co. KGaA fundamental analysis

No fundamental analysis for Fresenius Medical Care AG & Co. KGaA yet.

Fresenius Medical Care AG & Co. KGaA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis ser…

Full company profile